Abstract:Summary Neurodegenerative diseases are characterized by numerous markers of progression and clinical endpoints. For instance, multiple system atrophy (MSA), a rare neurodegenerative synucleinopathy, is characterized by various combinations of progressive autonomic failure and motor dysfunction, and a very poor prognosis. Describing the progression of such complex and multi‐dimensional diseases is particularly difficult. One has to simultaneously account for the assessment of multivariate markers over time, the occurrence of clinical endpoints, and a highly suspected heterogeneity between patients. Yet, such description is crucial for understanding the natural history of the disease, staging patients diagnosed with the disease, unravelling subphenotypes, and predicting the prognosis. Through the example of MSA progression, we show how a latent class approach modeling multiple repeated markers and clinical endpoints can help describe complex disease progression and identify subphenotypes for exploring new pathological hypotheses. The proposed joint latent class model includes class‐specific multivariate mixed models to handle multivariate repeated biomarkers possibly summarized into latent dimensions and class‐and‐cause‐specific proportional hazard models to handle time‐to‐event data. Maximum likelihood estimation procedure, validated through simulations is available in the lcmm R package. In the French MSA cohort comprising data of 598 patients during up to 13 years, five subphenotypes of MSA were identified that differ by the sequence and shape of biomarkers degradation, and the associated risk of death. In posterior analyses, the five subphenotypes were used to explore the association between clinical progression and external imaging and fluid biomarkers, while properly accounting for the uncertainty in the subphenotypes membership.

Composite likelihood and maximum likelihood methods for joint latent class modeling of disease prevalence and high-dimensional semicontinuous biomarker data

Composite likelihood and maximum likelihood methods for joint latent class modeling of disease prevalence and high-dimensional semicontinuous biomarker data

Latent Class Analysis with Semi-parametric Proportional Hazards Submodel for Time-to-event Data

Joint Models for Time-to-Event Data and Longitudinal Biomarkers of High Dimension

SEMIPARAMETRIC LATENT-CLASS MODELS FOR MULTIVARIATE LONGITUDINAL AND SURVIVAL DATA

Latent Class Dynamic Mediation Model with Application to Smoking Cessation Data

Bayesian Latent-Class Mixed-Effect Hybrid Models for Dyadic Longitudinal Data with Non-Ignorable Dropouts.

Semiparametric maximum likelihood estimation with two-phase stratified case-control sampling

Composite likelihood for extreme values

Maximum likelihood estimation of semiparametric mixture component models for competing risks data

Maximum likelihood estimation for semiparametric regression models with interval-censored multistate data

Latent Class Proportional Hazards Regression with Heterogeneous Survival Data

Joint model-based clustering of nonlinear longitudinal trajectories and associated time-to-event data analysis, linked by latent class membership: with application to AIDS clinical studies

A joint latent class model of longitudinal and survival data with a time-varying membership probability

A New Semiparametric Transformation Approach to Disease Diagnosis with Multiple Biomarkers

Combining Biomarkers to Improve Diagnostic Accuracy in Detecting Diseases With Group‐Tested Data

Bayesian joint analysis of heterogeneous- and skewed-longitudinal data and a binary outcome, with application to AIDS clinical studies

Simultaneous Modeling of Multivariate Heterogeneous Responses and Heteroskedasticity Via a Two‐stage Composite Likelihood

Maximum Likelihood Estimation for Semiparametric Regression Models with Interval-Censored Multi-State Data

Describing complex disease progression using joint latent class models for multivariate longitudinal markers and clinical endpoints

Keeping continuous diagnostic data continuous: Application of Bayesian latent class models in veterinary research